Navigation Links
Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
Date:4/6/2011

llion ($15 million per year) over the two years beginning with the first commercial sale of DIFICID. Cubist is also eligible to receive an additional $5 million in the first year after first commercial sale and $12.5 million in the second year of the agreement if mutually agreed upon annual sales targets are achieved, as well as a portion of Optimer's gross profits from any sales above the specified annual sales target levels.

Scheduled Conference Call

Optimer will host a conference call today at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss the outcome of the Anti-Infective Drugs Advisory Committee as well as the Cubist collaboration. To participate in the conference call, please dial (877) 280-7280 from the U.S., or (678) 825-8232 for international callers. Please specify to the operator that you would like to join "Optimer's Conference Call." The conference call will be webcast live under the Investors section of Optimer's website at www.optimerpharma.com, where it will be archived for 30 days following the call. Please connect to Optimer's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. 

About DIFICID™ (Fidaxomicin)

DIFICID™ (fidaxomicin) is an investigational antibiotic with a novel mechanism of action, which inhibits the bacterial enzyme RNA polymerase, resulting in the rapid killing of C. difficile. The narrow-spectrum profile of DIFICID eradicates C. difficile selectively with minimal disruption to the normal intestinal flora, while the alternative antibiotics used to treat CDI, metronidazole and vancomycin, have been shown to disrupt the gut flora. DIFICID facilitates the return of normal physiological conditions in the colon which may be responsible for reducing CDI recurrence rates. In two Phase 3 trials for the treatment of CD
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
2. Trading Halted Today in Optimer Pharmaceuticals Stock
3. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
4. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
5. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
6. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
7. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
8. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
9. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
10. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... --  Evana Automation Specialists , a leading Systems Integrator ... recently received a contract to provide a robotic assembly ... solution will help error-proof the process of assembling catheter ... labor. A catheter adapter, connector and ... The robot will pick the adapter, connector and O-ring ...
(Date:9/16/2014)... , Sept. 16, 2014 On September 25 ... exhibition focusing on medical design and manufacturing - MEDTEC ... Shanghai World Expo Exhibition & Convention Center, bringing together ... and regions to showcase their latest medical-grade raw materials, ... only one week remaining for free visitor pre-registration to ...
(Date:9/16/2014)... The Lupus Foundation of America and Eli ... released results from UNVEIL: understanding the impact of lupus, ... journey and the challenges not only for those living ... study, which involved over 1,000 people with lupus and ... all aspects of life including family, work, finances, treatment ...
Breaking Medicine Technology:Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5
... 2, 2011 Floridians turned in nearly 5,500 pounds ... pharmacies and law enforcement offices throughout the state during ... more than doubling the amount dropped off at 38 ... Back Day, the National Association of Drug Diversion ...
... 2, 2011 What do Robert DeNiro, Hugo Chavez, Rudy ... Mandela, Colin Powell, Frank Zappa, Telly Savalas, Bill Bixby and ... answer is prostate cancer, then you would be correct. ... all diagnosed and successfully treated.  Chavez, the President of Venezuela, ...
Cached Medicine Technology:NADDI and the C.A.R.E.S. Alliance Co-Sponsor Successful Drug Take Back Day 2
(Date:9/16/2014)... magnesium sulfate is routinely given to pregnant women at ... won,t provide any long-term benefits for infants. ... pregnant women, researchers in Australia found it had no ... those children when they were assessed at between 6 ... negate the fact that the drug is helpful in ...
(Date:9/16/2014)... therapy as part of breast conservation is the ... positive (HR+) invasive breast cancer. A new study ... shows that combination may not be necessary for ... The results, which Fox Chase researchers presented at ... Meeting on Sunday, September 14, suggest that low-risk ...
(Date:9/16/2014)... Programs and policies that promote health and disease ... in savings for the US health system, according to ... spur these types of improvements, the National Quality Forum ... across the country to field test the NQF Action ... designed to assist groups working together to improve health ...
(Date:9/16/2014)... Silver Spring, Md. (PRWEB) September 16, 2014 ... University of Colorado Anschutz Medical Campus and Children’s ... 2014. PHA is the country’s leading pulmonary hypertension association ... hypertension (PH) – a disease of the lungs that affects ... heart failure. Without treatment, mean survivability is only 2.8 years. ...
(Date:9/16/2014)... By Tara Haelle ... -- A new blood test is the first objective scientific ... claims. The test measures the levels of nine genetic ... test could also determine who will respond to cognitive behavioral ... depression, and could show whether the therapy worked, Northwestern University ...
Breaking Medicine News(10 mins):Health News:Researchers Don't See Long-Term Benefits From Drug for Preemies 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3Health News:NQF Seeks Field Testing Groups for Population Health Guide 2Health News:NQF Seeks Field Testing Groups for Population Health Guide 3Health News:Help Fight Pulmonary Hypertension at the Colorado PH in the Park 2014 2Health News:Blood Test Spots Adult Depression: Study 2Health News:Blood Test Spots Adult Depression: Study 3
... major medical advances improved survival , TUESDAY, ... has reduced the death rate for patients hospitalized for ... deal with these daily emergencies, a nationwide study finds. ... for Medicare patients treated for heart attacks decreased, from ...
... ACMIC reduces costs ... ... -- Corticon Technologies , the leading provider of Business Rules Management Systems (BRMS) ... gone live with an upgraded claims processing system built on Corticon BRMS. , ,For ...
... , Price of Diabetes ... , , BETHESDA, Md., Aug. ... people with diabetes has been misconstrued during recent health care ... the nation,s leading professional organization of doctors of podiatric medicine ...
... OKLAHOMA CITY, Aug. 18 Almost everyone who lives a long life ... at some point. As more Americans live into their 70s and ... tips that may delay onset, and how to decide when it is time ... August is Cataract Awareness Month, and the Oklahoma Academy of Ophthalmology (OAO) encourages ...
... maybe depressed, new U.S. survey of Internet players finds ... video gamer is not the stereotypical adolescent locked to ... a new U.S. survey, are 35-year-old adults, many of ... , The surprising findings also show that the health ...
... ... application called Med Records to Go(tm) , that stores electronic medical ... hospital or medical clinic admissions. Introduced by the Vital Record Corporation ... record and store personal health information and external documents for emergency viewing ...
Cached Medicine News:Health News:Hospitals Reduce Heart Attack Deaths 2Health News:Hospitals Reduce Heart Attack Deaths 3Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 2Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 3Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 4Health News:American Podiatric Medical Association Corrects President's Misstatement on Foot Amputation Costs 2Health News:What Oklahomans Should Know About Cataract Surgery 2Health News:What Oklahomans Should Know About Cataract Surgery 3Health News:Video Gamers Older Than You Think 2Health News:Video Gamers Older Than You Think 3Health News:Video Gamers Older Than You Think 4Health News:"Med Records to Go" Stores Document and Image Files of Medical Facilities for Emergency Viewing 2Health News:"Med Records to Go" Stores Document and Image Files of Medical Facilities for Emergency Viewing 3
... cervical spine manipulation. Prevent dental and soft ... effective alternative to X-ray. Light-guided intubation is ... tissues in the neck. This technique takes ... trachea relative to the esophagus. A well-defined, ...
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
Bivona® stylets are manufactured of malleable stainless steel wire. The length can be adjusted by sliding the attached silicone stopper. The Blue Line® tracheal tube introducer (bougie) is de...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
Medicine Products: